Chong Kun Dang Pharmaceutical Corp
KRX:185750
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
86 000
133 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Chong Kun Dang Pharmaceutical Corp
Cash Flow Statement
Cash Flow Statement
Chong Kun Dang Pharmaceutical Corp
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
59 847
|
44 361
|
70 842
|
79 978
|
98 573
|
119 191
|
137 220
|
213 602
|
204 184
|
216 061
|
191 491
|
|
| Depreciation & Amortization |
35 519
|
30 716
|
32 279
|
33 598
|
34 692
|
35 566
|
36 643
|
37 030
|
37 269
|
37 527
|
38 408
|
|
| Other Non-Cash Items |
79 930
|
66 390
|
53 394
|
51 538
|
40 409
|
34 018
|
32 520
|
52 783
|
63 488
|
42 635
|
40 660
|
|
| Cash Taxes Paid |
56 248
|
36 369
|
16 585
|
15 561
|
7 679
|
9 148
|
5 619
|
11 812
|
15 858
|
38 348
|
35 243
|
|
| Cash Interest Paid |
5 081
|
5 204
|
5 757
|
6 444
|
7 297
|
7 827
|
8 319
|
8 631
|
8 393
|
8 155
|
7 922
|
|
| Change in Working Capital |
(155 953)
|
(122 354)
|
(144 396)
|
(97 379)
|
(69 830)
|
(63 178)
|
531
|
14 745
|
16 188
|
(38 398)
|
(85 318)
|
|
| Cash from Operating Activities |
19 344
N/A
|
19 113
-1%
|
12 119
-37%
|
67 734
+459%
|
103 844
+53%
|
125 597
+21%
|
206 913
+65%
|
318 160
+54%
|
321 128
+1%
|
257 825
-20%
|
185 241
-28%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(63 176)
|
(43 934)
|
(43 955)
|
(53 065)
|
(52 840)
|
(72 734)
|
(72 119)
|
(68 806)
|
(71 931)
|
(61 810)
|
(65 637)
|
|
| Other Items |
(58 009)
|
(67 314)
|
(69 508)
|
(12 316)
|
11 603
|
2 261
|
24 012
|
(102 507)
|
(139 143)
|
(88 802)
|
(106 262)
|
|
| Cash from Investing Activities |
(121 185)
N/A
|
(111 248)
+8%
|
(113 463)
-2%
|
(65 380)
+42%
|
(41 237)
+37%
|
(70 473)
-71%
|
(48 107)
+32%
|
(171 313)
-256%
|
(211 074)
-23%
|
(150 613)
+29%
|
(171 899)
-14%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
(3 824)
|
(1 888)
|
(1 888)
|
(1 888)
|
(1 701)
|
(1 701)
|
(1 701)
|
(6 025)
|
(8 174)
|
(14 222)
|
(15 496)
|
|
| Net Issuance of Debt |
97 099
|
96 857
|
(3 119)
|
(3 213)
|
(4 085)
|
(10 202)
|
(25 126)
|
(26 050)
|
(27 730)
|
(21 954)
|
(7 499)
|
|
| Cash Paid for Dividends |
0
|
(11 239)
|
(11 239)
|
(11 239)
|
0
|
(11 609)
|
(11 609)
|
(11 609)
|
0
|
(13 331)
|
(13 331)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
(14)
|
(32)
|
(27)
|
|
| Cash from Financing Activities |
82 467
N/A
|
83 730
+2%
|
(16 246)
N/A
|
(16 340)
-1%
|
(17 025)
-4%
|
(23 512)
-38%
|
(38 435)
-63%
|
(43 700)
-14%
|
(47 526)
-9%
|
(49 538)
-4%
|
(36 353)
+27%
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
1 020
|
921
|
640
|
(410)
|
(6)
|
(496)
|
(721)
|
(918)
|
216
|
1 242
|
57
|
|
| Net Change in Cash |
(18 353)
N/A
|
(7 484)
+59%
|
(116 949)
-1 463%
|
(14 396)
+88%
|
45 576
N/A
|
31 117
-32%
|
119 650
+285%
|
102 229
-15%
|
62 744
-39%
|
58 916
-6%
|
(22 954)
N/A
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(43 832)
N/A
|
(24 821)
+43%
|
(31 835)
-28%
|
14 670
N/A
|
51 004
+248%
|
52 863
+4%
|
134 793
+155%
|
249 354
+85%
|
249 198
0%
|
196 015
-21%
|
119 604
-39%
|
|
You don't have any saved screeners yet
